These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 26521435)

  • 1. [Recent advances in the quantification of drug metabolizing enzymes and transporters by proteomic approach].
    Yang B; Wang J; Cong YT; Hu LH; Gu JK
    Yao Xue Xue Bao; 2015 Jun; 50(6):668-74. PubMed ID: 26521435
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Translational value of liquid chromatography coupled with tandem mass spectrometry-based quantitative proteomics for in vitro-in vivo extrapolation of drug metabolism and transport and considerations in selecting appropriate techniques.
    Al Feteisi H; Achour B; Rostami-Hodjegan A; Barber J
    Expert Opin Drug Metab Toxicol; 2015; 11(9):1357-69. PubMed ID: 26108733
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proteomic Quantification of Changes in Abundance of Drug-Metabolizing Enzymes and Drug Transporters in Human Liver Cirrhosis: Different Methods, Similar Outcomes.
    El-Khateeb E; Al-Majdoub ZM; Rostami-Hodjegan A; Barber J; Achour B
    Drug Metab Dispos; 2021 Aug; 49(8):610-618. PubMed ID: 34045218
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Liquid Chromatography-Tandem Mass Spectrometry (LC-MS/MS)-Based Proteomics of Drug-Metabolizing Enzymes and Transporters.
    Li J; Zhu HJ
    Molecules; 2020 Jun; 25(11):. PubMed ID: 32545386
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Variability in Mass Spectrometry-based Quantification of Clinically Relevant Drug Transporters and Drug Metabolizing Enzymes.
    Wegler C; Gaugaz FZ; Andersson TB; Wiśniewski JR; Busch D; Gröer C; Oswald S; Norén A; Weiss F; Hammer HS; Joos TO; Poetz O; Achour B; Rostami-Hodjegan A; van de Steeg E; Wortelboer HM; Artursson P
    Mol Pharm; 2017 Sep; 14(9):3142-3151. PubMed ID: 28767254
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Choice of LC-MS methods for the absolute quantification of drug-metabolizing enzymes and transporters in human tissue: a comparative cost analysis.
    Al Feteisi H; Achour B; Barber J; Rostami-Hodjegan A
    AAPS J; 2015 Mar; 17(2):438-46. PubMed ID: 25663651
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Data-independent acquisition (DIA): An emerging proteomics technology for analysis of drug-metabolizing enzymes and transporters.
    Li J; Smith LS; Zhu HJ
    Drug Discov Today Technol; 2021 Dec; 39():49-56. PubMed ID: 34906325
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Application of Quantitative Targeted Absolute Proteomics to Profile Protein Expression Changes of Hepatic Transporters and Metabolizing Enzymes During Cholic Acid-Promoted Liver Regeneration.
    Miura T; Tachikawa M; Ohtsuka H; Fukase K; Nakayama S; Sakata N; Motoi F; Naitoh T; Katayose Y; Uchida Y; Ohtsuki S; Terasaki T; Unno M
    J Pharm Sci; 2017 Sep; 106(9):2499-2508. PubMed ID: 28249806
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Application of proteomics to understand maturation of drug metabolizing enzymes and transporters for the optimization of pediatric drug therapy.
    Streekstra EJ; Russel FGM; van de Steeg E; de Wildt SN
    Drug Discov Today Technol; 2021 Dec; 39():31-48. PubMed ID: 34906324
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Label-Free Quantitative Proteomics and Substrate-Based Mass Spectrometry Imaging of Xenobiotic Metabolizing Enzymes in Ex Vivo Human Skin and a Human Living Skin Equivalent Model.
    Couto N; Newton JRA; Russo C; Karunakaran E; Achour B; Al-Majdoub ZM; Sidaway J; Rostami-Hodjegan A; Clench MR; Barber J
    Drug Metab Dispos; 2021 Jan; 49(1):39-52. PubMed ID: 33139459
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetically humanized mouse models of drug metabolizing enzymes and transporters and their applications.
    Scheer N; Wolf CR
    Xenobiotica; 2014 Jan; 44(2):96-108. PubMed ID: 23845026
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Global Proteomic Analysis of Human Liver Microsomes: Rapid Characterization and Quantification of Hepatic Drug-Metabolizing Enzymes.
    Achour B; Al Feteisi H; Lanucara F; Rostami-Hodjegan A; Barber J
    Drug Metab Dispos; 2017 Jun; 45(6):666-675. PubMed ID: 28373266
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Personalized dosing from perspective of pharmacogenomics of drug metabolizing enzymes and transporters].
    Zhou Q; Yu LS; Zeng S
    Yao Xue Xue Bao; 2017 Jan; 52(1):1-7. PubMed ID: 29911367
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of Intestinal Flora on Protein Expression of Drug-Metabolizing Enzymes and Transporters in the Liver and Kidney of Germ-Free and Antibiotics-Treated Mice.
    Kuno T; Hirayama-Kurogi M; Ito S; Ohtsuki S
    Mol Pharm; 2016 Aug; 13(8):2691-701. PubMed ID: 27376980
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Direct Quantification of Cytochromes P450 and Drug Transporters-A Rapid, Targeted Mass Spectrometry-Based Immunoassay Panel for Tissues and Cell Culture Lysates.
    Weiß F; Hammer HS; Klein K; Planatscher H; Zanger UM; Norén A; Wegler C; Artursson P; Joos TO; Poetz O
    Drug Metab Dispos; 2018 Apr; 46(4):387-396. PubMed ID: 29343608
    [TBL] [Abstract][Full Text] [Related]  

  • 16. mRNA expression of drug metabolism enzymes and transporter genes at birth using human umbilical cord blood.
    Neyro V; Elie V; Médard Y; Jacqz-Aigrain E
    Fundam Clin Pharmacol; 2018 Aug; 32(4):422-435. PubMed ID: 29436076
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Absolute quantification and differential expression of drug transporters, cytochrome P450 enzymes, and UDP-glucuronosyltransferases in cultured primary human hepatocytes.
    Schaefer O; Ohtsuki S; Kawakami H; Inoue T; Liehner S; Saito A; Sakamoto A; Ishiguro N; Matsumaru T; Terasaki T; Ebner T
    Drug Metab Dispos; 2012 Jan; 40(1):93-103. PubMed ID: 21979928
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nuclear receptors and the regulation of drug-metabolizing enzymes and drug transporters: implications for interindividual variability in response to drugs.
    Urquhart BL; Tirona RG; Kim RB
    J Clin Pharmacol; 2007 May; 47(5):566-78. PubMed ID: 17442683
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Scientific perspectives on drug transporters and their role in drug interactions.
    Zhang L; Strong JM; Qiu W; Lesko LJ; Huang SM
    Mol Pharm; 2006; 3(1):62-9. PubMed ID: 16686370
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alterations of drug-metabolizing enzymes and transporters under diabetic conditions: what is the potential clinical significance?
    Chen F; Li DY; Zhang B; Sun JY; Sun F; Ji X; Qiu JC; Parker RB; Laizure SC; Xu J
    Drug Metab Rev; 2018 Aug; 50(3):369-397. PubMed ID: 30221555
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.